A biomarker trial of BR-DIM (BioResponse 3,3′-Diindolylmethane) in patients with prostate cancer who undergo prostatectomy.

被引：0
|
作者：
Heath, E. I.
Hwang, C.
Cher, M. L.
Heilbrun, L. K.
Powell, I.
Menon, M.
Li, J.
Heath, M.
Sethi, S.
Sarkar, F. H.
机构：
[1] Karmanos Canc Inst, Detroit, MI USA
[2] Henry Ford Hosp, Detroit, MI 48202 USA
[3] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e15185
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15185
引用
收藏
页数：1
相关论文
共 50 条
  • [41] SOCIOECONOMIC STATUS IS AN INDEPENDENT PREDICTOR OF BIOCHEMICAL RECURRENCE AMONG PATIENTS WITH PROSTATE CANCER WHO UNDERGO RADICAL PROSTATECTOMY
    Srougi, Victor
    Antunes, Alberto
    Reis, Sabrina
    Dall'Oglio, Marcos
    Nesrallah, Adriano
    Leite, Katia
    Srougi, Miguel
    JOURNAL OF UROLOGY, 2010, 183 (04): : E4 - E4
  • [42] Socioeconomic status is an independent predictor of biochemical recurrence among patients with prostate cancer who undergo radical prostatectomy
    Srougi, Victor
    Antunes, Alberto A.
    Reis, Sabrina T.
    Dall'Oglio, Marcos F.
    Nesrallah, Adriano J.
    Leite, Ktia R. M.
    Srougi, Miguel
    INTERNATIONAL BRAZ J UROL, 2011, 37 (04): : 507 - 513
  • [43] Multiple therapeutic and preventive effects of 3,3'-diindolylmethane on cancers including prostate cancer and high grade prostatic intraepithelial neoplasia
    William Weiben Zhang
    Zhenqing Feng
    Steven A Narad
    The Journal of Biomedical Research, 2014, 28 (05) : 339 - 348
  • [44] THERE IS NO WAY TO IDENTIFY PATIENTS WHO WILL HARBOR PT2A PROSTATE CANCER AT RADICAL PROSTATECTOMY. IMPLICATIONS FOR FOCAL THERAPIES
    Montorsi, Francesco
    Briganti, Alberto
    Suardi, Nazareno
    Capitanio, Umberto
    Abdollah, Firas
    Salonia, Andrea
    Barbieri, Luigi
    Freschi, Massimo
    Villa, Luca
    Zanni, Giuseppe
    Roscigno, Marco
    Rigatti, Patrizio
    JOURNAL OF UROLOGY, 2010, 183 (04): : E363 - E363
  • [45] Discerning the survival advantage among patients with prostate cancer who undergo radical prostatectomy or radiotherapy: The limitations of cancer registry data
    Williams, Stephen B.
    Huo, Jinhai
    Chamie, Karim
    Smaldone, Marc C.
    Kosarek, Christopher D.
    Fang, Justin E.
    Ynalvez, Leslie A.
    Kim, Simon P.
    Hoffman, Karen E.
    Giordano, Sharon H.
    Chapin, Brian F.
    CANCER, 2017, 123 (09) : 1617 - 1624
  • [46] 3,3′-Diindolylmethane (DIM) and derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5.
    Abdelrahim, Maen
    Newman, Kristen Kristen
    Vanderlaag, Kathy
    Samudio, Ismael
    Safe, Stephen
    CANCER RESEARCH, 2006, 66 (08)
  • [47] Regulation of carcinogenesis and mediation through Wnt/β-catenin signaling by 3,3′-diindolylmethane in an enzalutamide-resistant prostate cancer cell line
    Tsao, Chih-Wei
    Li, Jia-Sin
    Lin, Ya-Wen
    Wu, Sheng-Tang
    Cha, Tai-Lung
    Liu, Chin-Yu
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [48] Efficacy evaluation of BR-9001, a SMEDDS formulation of 3,3'-diindolylmethane, as an inhibitor of preneoplastic and neoplastic lesion development in the prostate of Hi-Myc mice
    Murillo, Genoveva
    Qualter, Gina
    Peng, Xinjian
    Muzzio, Miguel
    Glaze, Elizabeth R.
    Mohammed, Altaf
    Bosland, Maarten C.
    McCormick, David L.
    CANCER RESEARCH, 2022, 82 (12)
  • [49] Regulation of carcinogenesis and mediation through Wnt/β-catenin signaling by 3,3′-diindolylmethane in an enzalutamide-resistant prostate cancer cell line
    Chih-Wei Tsao
    Jia-Sin Li
    Ya-Wen Lin
    Sheng-Tang Wu
    Tai-Lung Cha
    Chin-Yu Liu
    Scientific Reports, 11
  • [50] Does Race Affect Postoperative Outcomes in Patients With Low-Risk Prostate Cancer Who Undergo Radical Prostatectomy?
    Resnick, M. J.
    Canter, D. J.
    Guzzo, T. J.
    Brucker, B. M.
    Bergey, M.
    Sonnad, S. S.
    Wein, A. J.
    Malkowicz, S. B.
    UROLOGY, 2009, 73 (03) : 620 - 623
12345